On this episode of Pharmacy Focus, experts discuss World Psychedelics Day, which is June 20. Experts will also discuss goals of World Psychedelics Day in increasing awareness and appreciation of psychedelics' therapeutic potential while honoring traditional knowledge. Experts cover the history of psychedelics, current research on psychedelic therapies for conditions like PTSD and depression, and future directions. Proper education, screening, medication management and harm reduction practices are highlighted as best ways that pharmacists can get involved.

Guests Include:

Mark Achbar, WPD Founder

Sarah Butterfield, WPD Creative Director

Rev. Shannon Smadella, WPD Operations & Partnerships Director

Sandra Dreisbach, PhD, WPD Ethics Director

Dennis Mckenna, Director and President of the Mckenna Academy

Kevin Lanzo, PharmD, co-founder of the Psychedelic Pharmacists Association (PPA)

Kristin Speer, PharmD, BCPS, co-founder of the PPA

References

1. Pharmacy Times. Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions. February 8. 2022. Accessed June 13, 2024. https://www.pharmacytimes.com/view/survey-shows-65-of-affected-americans-want-access-to-psychedelic-treatments-for-mental-health-conditions

2. Gallagher A. Psychedelic Medicine Could Fill Care Gap in Psychiatric Care. Pharmacy Times. April 10, 2024. Accessed June 13, 2024. https://www.pharmacytimes.com/view/psychedelic-medicine-could-fill-care-gap-in-psychiatric-care

3. Gallagher A. Is 2024 the Year for Psychedelic Medicine?. Pharmacy Times. April 4, 2024. Accessed June 13, 2024. https://www.pharmacytimes.com/view/is-2024-the-year-for-psychedelic-medicine-

4. Antrim A. FDA Advisory Panel Rejects MDMA-Assisted Therapy for PTSD. Pharmacy Times. June 4, 2024. Accessed June 13, 2024. https://www.pharmacytimes.com/view/fda-advisory-panel-rejects-mdma-assisted-therapy-for-ptsd